Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Acta Physiol (Oxf). 2013 Apr 15;208(2):172–179. doi: 10.1111/apha.12097

Figure 1.

Figure 1

(A) Area at risk expressed in percent of the left ventricle (LV), (B) infarct size expressed in percent of the area at risk and (C) infarct size expressed in percent of the LV in rats included in the acute protocol (30 min ischemia and 2 h reperfusion). The groups were randomized to treatment with vehicle or the arginase inhibitor nor-NOHA. Significant differences from vehicle are shown; *P<0.05, **P<0.01.